Literature DB >> 14984858

Prolonged neuromuscular blockade as a result of malnutrition-induced pseudocholinesterase deficiency.

Ahtsham Niazi1, Irene E Leonard, Breda O'Kelly.   

Abstract

Mivacurium is a short-acting neuromuscular blocking drug, ideal for short surgical procedures. The brief duration of action depends on rapid hydrolysis by plasma cholinesterase. An inherited or acquired deficiency of plasma cholinesterase can prolong the effect of mivacurium. We present an unusual case of unanticipated postoperative apnea following mivacurium administration, as a result of acquired plasma cholinesterase deficiency, in a patient with previous uneventful exposure to both mivacurium and suxamethonium (succinylcholine).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984858     DOI: 10.1016/j.jclinane.2003.02.010

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  5 in total

Review 1.  Tropical medicine and anaesthesia 1.

Authors:  T Bashford; V Howell
Journal:  BJA Educ       Date:  2017-12-02

2.  Teaching corner: A new method of measuring mid upper arm circumference at Queen Elizabeth Central hospital, Blantyre, Malawi.

Authors:  G Pollach; S Mndolo
Journal:  Malawi Med J       Date:  2011-03       Impact factor: 0.875

3.  Neuromuscular pharmacodynamics of mivacurium in adults with major burns.

Authors:  T-H Han; J A J Martyn
Journal:  Br J Anaesth       Date:  2011-02-24       Impact factor: 9.166

4.  Pseudocholinesterase Enzyme Deficiency in Adıyaman City Area.

Authors:  Ruslan Abdullayev; Ömer Burak Küçükebe; Recai Kaya; Bülent Çelik; Hatice Kuşderci; Mehmet Duran; Öznur Uludağ; Mesut Öterkuş; Aysel Buyrukcan; Ülkü Sabuncu; Abdullah Arpacı
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-12-01

5.  Reversal of succinylcholine induced apnea with an organophosphate scavenging recombinant butyrylcholinesterase.

Authors:  Brian C Geyer; Katherine E Larrimore; Jacquelyn Kilbourne; Latha Kannan; Tsafrir S Mor
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.